Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229042553> ?p ?o ?g. }
- W4229042553 endingPage "103715" @default.
- W4229042553 startingPage "103715" @default.
- W4229042553 abstract "Low retention is a persistent challenge in the delivery of buprenorphine treatment for opioid use disorder (OUD). The goal of this study was to identify provider factors that could drive differences in treatment retention while accounting for the contribution of patient characteristics to retention. We developed a novel a mixed-methods approach to explore provider factors that could drive retention while accounting for patient characteristics. We used Medicaid claims data from North Carolina in the United States to identify patient characteristics associated with higher retention. We then identified providers who achieved high and low retention rates. We matched high- and low-retention providers on their patients’ characteristics. This matching created high- and low-retention provider groups whose patients had similar characteristics. We then interviewed providers while blinded to which belonged in the high- and low-retention groups on aspects of their practice that could affect retention rates, such as treatment criteria, treatment cost, and services offered. Less than half of patients achieved 180-day treatment retention with large differences by race and ethnicity. We did not find evidence that providers who achieved higher retention consistently did so by providing more comprehensive services or selecting for more stable patients. Rather, our findings suggest use of “high-threshold” clinical approaches, such as requiring participation in psychosocial services or strictly limiting dosages, explain differences in retention rates between providers whose patients have similar characteristics. All low-retention providers interviewed used a high-threshold practice compared to half of high-retention providers interviewed. Requiring patients to participate in psychosocial services, which were often paid out-of-pocket, appeared to be especially important in limiting retention. Providers who adopt low-threshold approaches to treatment may achiever higher retention rates than those who adopt high-threshold approaches. Addressing cost barriers and systemic racism are likely also necessary for improving buprenorphine treatment retention." @default.
- W4229042553 created "2022-05-08" @default.
- W4229042553 creator A5004397320 @default.
- W4229042553 creator A5010590004 @default.
- W4229042553 creator A5018339547 @default.
- W4229042553 creator A5025911451 @default.
- W4229042553 creator A5040974781 @default.
- W4229042553 creator A5053685758 @default.
- W4229042553 creator A5071362937 @default.
- W4229042553 creator A5077578339 @default.
- W4229042553 date "2022-07-01" @default.
- W4229042553 modified "2023-10-03" @default.
- W4229042553 title "A mixed methods study of provider factors in buprenorphine treatment retention" @default.
- W4229042553 cites W1850864270 @default.
- W4229042553 cites W1970939183 @default.
- W4229042553 cites W1993181943 @default.
- W4229042553 cites W1994526997 @default.
- W4229042553 cites W2006178704 @default.
- W4229042553 cites W2048135932 @default.
- W4229042553 cites W2068305683 @default.
- W4229042553 cites W2085028749 @default.
- W4229042553 cites W2092115346 @default.
- W4229042553 cites W2102695736 @default.
- W4229042553 cites W2125833000 @default.
- W4229042553 cites W2129660502 @default.
- W4229042553 cites W2150625569 @default.
- W4229042553 cites W2248705888 @default.
- W4229042553 cites W2404633355 @default.
- W4229042553 cites W2564687864 @default.
- W4229042553 cites W2566316894 @default.
- W4229042553 cites W2594519269 @default.
- W4229042553 cites W2608446001 @default.
- W4229042553 cites W2725813995 @default.
- W4229042553 cites W2781354429 @default.
- W4229042553 cites W2890254074 @default.
- W4229042553 cites W2898142040 @default.
- W4229042553 cites W2912522026 @default.
- W4229042553 cites W2964919508 @default.
- W4229042553 cites W2971108112 @default.
- W4229042553 cites W2977651311 @default.
- W4229042553 cites W3011008216 @default.
- W4229042553 cites W3014308061 @default.
- W4229042553 cites W3047435281 @default.
- W4229042553 cites W3048499077 @default.
- W4229042553 cites W3153691975 @default.
- W4229042553 cites W3171829322 @default.
- W4229042553 cites W3197901639 @default.
- W4229042553 cites W3200788592 @default.
- W4229042553 cites W4249308354 @default.
- W4229042553 cites W4376043520 @default.
- W4229042553 doi "https://doi.org/10.1016/j.drugpo.2022.103715" @default.
- W4229042553 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35533634" @default.
- W4229042553 hasPublicationYear "2022" @default.
- W4229042553 type Work @default.
- W4229042553 citedByCount "3" @default.
- W4229042553 countsByYear W42290425532023 @default.
- W4229042553 crossrefType "journal-article" @default.
- W4229042553 hasAuthorship W4229042553A5004397320 @default.
- W4229042553 hasAuthorship W4229042553A5010590004 @default.
- W4229042553 hasAuthorship W4229042553A5018339547 @default.
- W4229042553 hasAuthorship W4229042553A5025911451 @default.
- W4229042553 hasAuthorship W4229042553A5040974781 @default.
- W4229042553 hasAuthorship W4229042553A5053685758 @default.
- W4229042553 hasAuthorship W4229042553A5071362937 @default.
- W4229042553 hasAuthorship W4229042553A5077578339 @default.
- W4229042553 hasBestOaLocation W42290425532 @default.
- W4229042553 hasConcept C118552586 @default.
- W4229042553 hasConcept C126322002 @default.
- W4229042553 hasConcept C126894567 @default.
- W4229042553 hasConcept C144133560 @default.
- W4229042553 hasConcept C150966472 @default.
- W4229042553 hasConcept C160735492 @default.
- W4229042553 hasConcept C162324750 @default.
- W4229042553 hasConcept C162853370 @default.
- W4229042553 hasConcept C170493617 @default.
- W4229042553 hasConcept C2776534028 @default.
- W4229042553 hasConcept C2778949969 @default.
- W4229042553 hasConcept C2779091618 @default.
- W4229042553 hasConcept C2779418921 @default.
- W4229042553 hasConcept C2780866740 @default.
- W4229042553 hasConcept C2781063702 @default.
- W4229042553 hasConcept C38652104 @default.
- W4229042553 hasConcept C41008148 @default.
- W4229042553 hasConcept C50522688 @default.
- W4229042553 hasConcept C71924100 @default.
- W4229042553 hasConcept C79736992 @default.
- W4229042553 hasConceptScore W4229042553C118552586 @default.
- W4229042553 hasConceptScore W4229042553C126322002 @default.
- W4229042553 hasConceptScore W4229042553C126894567 @default.
- W4229042553 hasConceptScore W4229042553C144133560 @default.
- W4229042553 hasConceptScore W4229042553C150966472 @default.
- W4229042553 hasConceptScore W4229042553C160735492 @default.
- W4229042553 hasConceptScore W4229042553C162324750 @default.
- W4229042553 hasConceptScore W4229042553C162853370 @default.
- W4229042553 hasConceptScore W4229042553C170493617 @default.
- W4229042553 hasConceptScore W4229042553C2776534028 @default.
- W4229042553 hasConceptScore W4229042553C2778949969 @default.
- W4229042553 hasConceptScore W4229042553C2779091618 @default.